BINDONG LIU, PHD, LAB STARTUP PACKAGE: HIV IN AFRICAN AMERICANS
BINDONG LIU,博士,实验室启动计划:非洲裔美国人中的艾滋病毒
基本信息
- 批准号:7724718
- 负责人:
- 金额:$ 19.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2009-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAffectAfrican AmericanAllelesAnti-Retroviral AgentsCD4 Positive T LymphocytesCodon NucleotidesComputer Retrieval of Information on Scientific Projects DatabaseConditionCytidine DeaminaseDNADefectDisease ProgressionExonsFundingGenetic VariationGrantHIVHIV-1In VitroInstitutionNuclear ImportPopulationPreventionProtein FamilyRaceRateReportingResearchResearch PersonnelResourcesSourceTherapeuticTimeUnited States National Institutes of HealthVariantViral Reverse Transcriptionapolipoprotein B mRNA editing enzymeethnic minority populationimprovedinterestpolypeptideracial and ethnictransmission processviral DNA
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G (Apobec3G) is a newly defined host anti-retroviral factor. It belongs to a family of proteins that have cytidine deaminase activity. It is commonly believed that Apobec 3G restricts HIV-1 replication by inducing lethal G to A hypermutations in the newly synthesized viral DNA. It has also been observed that Apobec3G causes viral reverse transcription (RT), DNA nuclear import and integration of multiple steps of defects during HIV-1 replication. There are still some major gaps between the hypermutations and the multiple steps of defects. One of our research interest is to understand the details of how Apobec 3G restricts HIV-1 replication.
More and more in vitro evidence suggested that Apobec 3G is a potent host restriction factor against HIV-1 replication. It is still uncertain whether Apobec 3G also influence HIV transmission and disease progression. It has been reported that HIV and AIDS disproportionately affect African Americans at a rate that is 10 times greater than is found in the U.S. White population. Since 1996, more AIDS cases have occurred among African Americans than any other U.S racial/ethnic population. A recent study reported that one codon-changing variant, H186R in exon 4 of Apobec 3G, was polymorphic in African Americans. For African Americans, the variant allele 186R was strongly associated with decline in CD4 T cells, the 186R allele was also associated with accelerated progression to AIDS-defining conditions in African Americans. It would be interesting to know whether the variation of Apobec 3G will influence HIV transmission and disease progression. We will be interested to look at the relationship between the variation of Apobec 3G and HIV transmission and disease progression among different racial group through the study of Apobec 3G genetic variation and expression levels. It will assist in determining how to improve or develop new prevention or therapeutic approaches specific to ethnic minority populations.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
载脂蛋白B mRNA编辑酶催化多肽样3G(APOBEC3G)是新定义的宿主抗逆转录病毒因子。它属于具有胞苷脱氨酶活性的蛋白质家族。通常认为,APOBEC 3G通过将致命的G诱导到新合成的病毒DNA中的过度过度来限制HIV-1复制。还观察到,APOBEC3G引起病毒逆转录(RT),DNA核进口和HIV-1复制过程中多个缺陷步骤的整合。在过度渗透和缺陷的多个步骤之间仍然存在一些主要差距。我们的研究兴趣之一是了解APOBEC 3G如何限制HIV-1复制的细节。
越来越多的体外证据表明,APOBEC 3G是针对HIV-1复制的有效宿主限制因素。 APOBEC 3G仍然不确定是否也影响HIV传播和疾病进展。据报道,艾滋病毒和艾滋病对非裔美国人的影响不成比例,比美国白人人口高10倍。自1996年以来,非裔美国人中发生的艾滋病案件比其他任何美国种族/族裔人口都多。最近的一项研究报道,在非裔美国人中,APOBEC 3G外显子4中的一种改变密码子的变体H186R是多态性的。对于非洲裔美国人来说,186R的变体等位基因与CD4 T细胞的下降密切相关,186R等位基因也与加速到定义非洲裔美国人的艾滋病状况的进展有关。知道APOBEC 3G的变化是否会影响HIV传播和疾病进展会很有趣。通过研究APOBEC 3G遗传变异和表达水平,我们将有兴趣研究不同种族群体中APOBEC 3G的变异与HIV传播与疾病进展之间的关系。它将有助于确定如何改善或开发针对少数民族人群的新预防或治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bindong Liu其他文献
Bindong Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bindong Liu', 18)}}的其他基金
Characterizing a small molecule of Streptococcus cristatus for HIV drug design
表征用于 HIV 药物设计的冠状链球菌小分子
- 批准号:
8325100 - 财政年份:2009
- 资助金额:
$ 19.6万 - 项目类别:
Characterizing a small molecule of Streptococcus cristatus for HIV drug design
表征用于 HIV 药物设计的冠状链球菌小分子
- 批准号:
8138497 - 财政年份:2009
- 资助金额:
$ 19.6万 - 项目类别:
Characterizing a small molecule of Streptococcus cristatus for HIV drug design
表征用于 HIV 药物设计的冠状链球菌小分子
- 批准号:
7928223 - 财政年份:2009
- 资助金额:
$ 19.6万 - 项目类别:
Characterizing a small molecule of Streptococcus cristatus for HIV drug design
表征用于 HIV 药物设计的冠状链球菌小分子
- 批准号:
8521319 - 财政年份:2009
- 资助金额:
$ 19.6万 - 项目类别:
Characterizing a small molecule of Streptococcus cristatus for HIV drug design
表征用于 HIV 药物设计的冠状链球菌小分子
- 批准号:
7756561 - 财政年份:2009
- 资助金额:
$ 19.6万 - 项目类别:
Characterizing a small molecule of Streptococcus cristatus for HIV drug design
表征用于 HIV 药物设计的冠状链球菌小分子
- 批准号:
9348881 - 财政年份:2009
- 资助金额:
$ 19.6万 - 项目类别:
BINDONG LIU, PHD, LAB STARTUP PACKAGE: HIV IN AFRICAN AMERICANS
BINDONG LIU,博士,实验室启动计划:非洲裔美国人中的艾滋病毒
- 批准号:
7961279 - 财政年份:2008
- 资助金额:
$ 19.6万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Moving Beyond the Individual- A Data-driven Approach to Improving the Evidence on the Role of Community and Societal Determinants of HIV among Adolescent Girls and Young Women in Sub-Saharan Africa
超越个人——采用数据驱动的方法来改善关于艾滋病毒在撒哈拉以南非洲地区少女和年轻妇女中的社区和社会决定因素的作用的证据
- 批准号:
10619319 - 财政年份:2023
- 资助金额:
$ 19.6万 - 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686541 - 财政年份:2023
- 资助金额:
$ 19.6万 - 项目类别:
Examining Social Determinants of Antiretroviral Adherence Trajectories among African American Adults with HIV
检查非洲裔美国成人艾滋病毒感染者抗逆转录病毒药物依从轨迹的社会决定因素
- 批准号:
10700611 - 财政年份:2023
- 资助金额:
$ 19.6万 - 项目类别:
Multidisciplinary Practice-Based Research Training in Meharry Medical College, School of Dentistry
梅哈里医学院牙科学院多学科实践研究培训
- 批准号:
10754751 - 财政年份:2023
- 资助金额:
$ 19.6万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709602 - 财政年份:2022
- 资助金额:
$ 19.6万 - 项目类别: